Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
06/26/2003 | US20030121065 Polyfunctional base sequence and artificial gene containing the same |
06/26/2003 | US20030120071 Chemical compounds |
06/26/2003 | US20030120069 1,1'-((Propane-1,3-diyl)dioxy)bis((11aS)-7-methoxy-2 -methy lidene-1,2,3,11-tetrahydro-5H-pyrrolo(2,1-c)(1,4)benzodiazep in-5-one) derivatives; viricides, parasiticide, bactericides, gene therapy and treating cisplatin refractory disease |
06/26/2003 | US20030120045 Immobilization onto polyoxyethylene glycol |
06/26/2003 | US20030119881 Antivirals |
06/26/2003 | US20030119869 1-(Piperidin-4-yl)benzimidazole or -triazole derivatives; agonists and antagonist for beta-chemokine (chemotactic cytokines) receptors; viricides; HIV; antiarthritic agents; atherosclerosis, psoriasis, antiallergens; multiple sclerosis |
06/26/2003 | US20030119868 Gyrase inhibitors and uses thereof |
06/26/2003 | US20030119859 Useful in the prophylaxis and treatment of respiratory diseases |
06/26/2003 | US20030119857 Pyrimidinyl methyl indole derivatives with antibacterial activity |
06/26/2003 | US20030119854 Compounds and methods for modulating CXCR3 function |
06/26/2003 | US20030119848 A oxoquinolines or a 4-oxo-1,8-naphthyridines or 7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine derivative for the treatment of tuberculosis, exhibits no cross resistance |
06/26/2003 | US20030119838 Water-soluble phenylpyridazine compounds and compositions containing the same |
06/26/2003 | US20030119835 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
06/26/2003 | US20030119823 5-(1,1-dioxido-1,2-thiazinan-2-yl)-n-(4-fluorobenzyl)-8-hydrox y-1,6-naphthyridine-7-carboxamide; preventing or treating hiv or aids |
06/26/2003 | US20030119820 Substituted indoles |
06/26/2003 | US20030119816 Cycline-dependent kinase protein inhibitors; antiproliferative agents |
06/26/2003 | US20030119804 Otic microbial combination for treatment of animals with ruptured tympanic membrane |
06/26/2003 | US20030119803 In particular N-epsilon-amino acid substituted L-lysine derivatives possessing aspartyl protease inhibitory properties. |
06/26/2003 | US20030119793 CAK inhibitors and uses thereof |
06/26/2003 | US20030119784 Treating and preventing diarrhea and scours |
06/26/2003 | US20030119783 Aqueous compositions containing metronidazole |
06/26/2003 | US20030119780 Therapeutical treatments |
06/26/2003 | US20030119774 Compositions and methods for stimulating an immune response |
06/26/2003 | US20030119760 Water insoluble polymer, such as ethyl cellulose; and an optimizing agent, such as a Eudragit acrylic polymer, optionally containing lactose, dicalcium phosphate and/or tricalcium phosphate |
06/26/2003 | US20030119752 Inhibiting particularly the activity of hepatitis C virus NS3-NS4A protease; peptidomimetics having a bridged bicyclic moiety at the P2 position. |
06/26/2003 | US20030119749 Novel compounds possessing antibacterial, antifungal or antitumor activity |
06/26/2003 | US20030119748 Use for treatment of inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury. |
06/26/2003 | US20030119724 Contain a hepatic ligand to direct an oligomer or "payload" to a hepatocyte intracellularly via a receptor-mediated, ligand-directed pathway; solid phase synthesis |
06/26/2003 | US20030119722 Process for purifying glycopeptide phosphonate derivatives |
06/26/2003 | US20030119715 Prevent retinoid binding; antiaging agents; activation cell differentiation |
06/26/2003 | US20030119182 Immunotherapy; genetic engineering; anticancer agents |
06/26/2003 | US20030119170 Porcine reproductive and respiratory syndrome vaccine, based on isolate JA-142 |
06/26/2003 | US20030119148 Amino-terminally truncated rantes as chemokine antagonists |
06/26/2003 | US20030119111 G-protein coupled receptor, named 2871 receptor |
06/26/2003 | US20030119101 Bactericides, fungicides; transporter proteins |
06/26/2003 | US20030119095 Novel nucleic acid sequences encoding human vesicle transport protein-like and residue rat-like polypeptides |
06/26/2003 | US20030119076 B7-like polynucleotides, polypeptides, and antibodies |
06/26/2003 | US20030119013 Identification of essential genes of Aspergillus fumigatus and methods of use |
06/26/2003 | US20030118678 Plant extracts as antiproliferative, viricides and antiparasitic agents |
06/26/2003 | US20030118640 Pharmaceutical formulations comprising sodium amoxycillin and potassium clavulanate |
06/26/2003 | US20030118629 Water-in-oil emulsions with anionic groups, compositions, and methods |
06/26/2003 | US20030118611 Epitopes confirmed to be recognized by T-cells derived from herpetic lesions or uterine cervix; vaccination |
06/26/2003 | US20030118609 Administering a multimer of a human papillomavirus protein that is truncated at its amino terminus for immunization |
06/26/2003 | US20030118608 Comprising Lelystad Agent in a live, attenuated, dead, or recombinant form |
06/26/2003 | US20030118604 Comprising the 2-45 amino acid sequence of the N-terminal end of the core or nucleocapsid (p21) protein of the hepatitis C virus (HCV), excluding any protein or peptide compound comprising the N-terminal end |
06/26/2003 | US20030118602 Peptides and immunologically functional variants thereof which are immunogenic epitopes recognized by CD8+ class I major histocompatibility complex restricted cytotoxic T-lymphocytes of patients harboring latent human cytomegalovirus infection |
06/26/2003 | US20030118591 Treatment of severe anthrax infection particularly inhalation pneumonia or gastrointestinal anthrax antigen by passive transfer to infected patients of plasma or derivatives, such as gammaglobulins or antibodies, against bacillus anthracis |
06/26/2003 | US20030118588 Compound comprising an agonist anti-4-1BB antibody, or fragment thereof which stimulates the 4-1BB receptor; for treating tumors or infectious diseases |
06/26/2003 | US20030118564 Intra-tumoral administration of il-12 encoding nucleic acid molecules |
06/26/2003 | US20030118558 Lysin-deficient bacteriophages having reduced immunogenicity |
06/26/2003 | US20030118528 Topical delivery of codrugs |
06/26/2003 | US20030118507 Methods of using 46828, a human acyl-CoA synthetase |
06/26/2003 | US20030117579 Medical devices having antimicrobial coatings thereon |
06/26/2003 | CA2746308A1 Method for treating human papilloma virus |
06/26/2003 | CA2471589A1 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics |
06/26/2003 | CA2471237A1 Adhesion inhibition of moulds |
06/26/2003 | CA2471235A1 Inhibition of the asexual reproduction of fungi |
06/26/2003 | CA2470723A1 3,4-dihydro-1h-isoquinolin-2-yl-derivatives |
06/26/2003 | CA2470645A1 Streptococcus pneumoniae vaccine |
06/26/2003 | CA2470629A1 Stabilized brivudine topical formulations |
06/26/2003 | CA2470616A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
06/26/2003 | CA2470322A1 Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
06/26/2003 | CA2470315A1 Methods of detecting modification of genetic material |
06/26/2003 | CA2470236A1 Lactams as tachykinin antagonists |
06/26/2003 | CA2470060A1 Improvements in pharmaceutical compositions |
06/26/2003 | CA2469984A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
06/26/2003 | CA2469976A1 Improvements in pharmaceutical compositions |
06/26/2003 | CA2469879A1 A novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent |
06/26/2003 | CA2469799A1 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell |
06/26/2003 | CA2469785A1 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor |
06/26/2003 | CA2469205A1 Bioadhesive drug delivery system with enhanced gastric retention |
06/26/2003 | CA2469048A1 Quinolinones as prostaglandin receptor ligands |
06/26/2003 | CA2468986A1 Radioopaque sustained release pharmaceutical system |
06/26/2003 | CA2468790A1 Chemokine mutants acting as chemokine antagonists |
06/26/2003 | CA2468690A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
06/26/2003 | CA2468448A1 Benzodiazepine derivatives, preparation thereof and use thereof |
06/26/2003 | CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
06/26/2003 | CA2467279A1 Solubilized topoisomerase poison agents |
06/26/2003 | CA2467271A1 Mycobacterial vaccine |
06/26/2003 | CA2464512A1 Outer membrane vesicles from gram negative bacteria and use as a vaccine |
06/26/2003 | CA2446292A1 Nucleic acid-associated proteins |
06/25/2003 | EP1321476A2 Binding protein |
06/25/2003 | EP1321463A1 Thiazole derivatives and their use for the treatment or prevention of Flavivirus infections |
06/25/2003 | EP1321147A1 Orally administrable solid ribavirin dosage forms and process for making them |
06/25/2003 | EP1320621A2 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
06/25/2003 | EP1320614A2 Novel proteases |
06/25/2003 | EP1320600A1 Transporters and ion channels |
06/25/2003 | EP1320599A2 Pd-l2 molecules: pd-1 ligands and uses therefor |
06/25/2003 | EP1320584A2 Transferases |
06/25/2003 | EP1320581A1 T cell receptor transfer into a candidate effector cell or a precursor thereof |
06/25/2003 | EP1320550A2 G-protein coupled receptors |
06/25/2003 | EP1320548A2 Transporters and ion channels |
06/25/2003 | EP1320547A1 Transfer factor from birds eggs |
06/25/2003 | EP1320540A2 Peptidomimetic protease inhibitors |
06/25/2003 | EP1320533A1 Prodrugs of a 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotic |
06/25/2003 | EP1320531A2 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
06/25/2003 | EP1320530A1 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists |
06/25/2003 | EP1320529A1 Quinoline derivatives as antibacterials |
06/25/2003 | EP1320525A1 Antibacterial mutilins |
06/25/2003 | EP1320384A1 The synergetic effects of hgf and antibacterial treatment |